Five Takeaways from New Consensus Recommendations for CT Imaging and Reporting in Patients with CAD
In an update of the original CAD-RADS™ consensus document on coronary artery disease (CAD) imaging and reporting published in 2016, expert panelists incorporated emerging evidence for CAD-RADS 2.0 to recommend new categorization for coronary plaque burden and suggested modifiers to reflect the level of ischemia and high-risk plaque in patients undergoing cardiac computed tomography.
Ultrasound-Based Breast Imaging Device Gets FDA Clearance for Fibroglandular Volume Metrics
The ability of QT Imaging’s QTscan, a quantitative transmission ultrasound modality, to calculate the ratio of fibroglandular volume to total breast volume may facilitate assessment of ongoing breast cancer treatments or selective hormone receptor modulation therapies.
FDA Approves New MRI Contrast Agent Gadopiclenol
Requiring only half of the gadolinium dose of current non-specific gadolinium-based contrast agents (GBCAs), gadopiclenol can be utilized with magnetic resonance imaging (MRI) to help detect lesions with abnormal vascularity in the central nervous system and other areas of the body.
New Mammography Study Examines Association Between Breast Density Changes and Breast Cancer Risk
In a retrospective review involving over 2.2 million women with three consecutive biennial mammography screenings and no history of breast cancer, researchers noted that for premenopausal women with fatty breasts at baseline, increasing breast density at subsequent screenings led to significantly elevated hazard ratios ranging from 1.45 to 1.93 for the risk of breast cancer.
Study Shows Adjunctive Benefit of Pre-Biopsy MRI for Diagnosing Prostate Cancer
Emerging research suggests that combining pre-biopsy magnetic resonance imaging (MRI) with prostate-specific antigen (PSA) testing more than triples the specificity rate for detecting clinically significant prostate cancer in comparison to sole reliance on a PSA level greater than or equal to 4 ng/mL.
Post-Vaccine Axillary Lymphadenopathy: What a New Chest MRI Study Reveals
In a new study looking at the development of axillary lymphadenopathy after a second dose of COVID-19 vaccination, researchers found that those who had the Moderna COVID-19 vaccine were 21 percent more likely to have the post-vaccine side effect in comparison to those who had the Pfizer-BioNtech COVID-19 vaccine.
FDA Grants 510(k) Clearance to Chiropractic Straight Arm Radiography System
Combining low-cost, high-resolution radiography with dynamic imaging capabilities and design attributes to optimize workflow efficiency, the Chiropractic Straight Arm system may enhance musculoskeletal imaging.
Philips Set to Launch FetView Fetal Ultrasound Platform at ISUOG Conference
Emphasizing the digitalization of OB/GYN workflows and patient management, the cloud-based system reportedly facilitates real-time access to fetal ultrasound images and related data from any ultrasound system.
What a New Study Reveals About Radiographers and Mammography Assessment
In a new United Kingdom study comparing radiologist and radiographer assessment of over 1.4 million digital mammograms, researchers said there were no significant differences with cancer detection rates or recall rates.
Could a New Deep Learning Tool Enhance CT Detection of Pancreatic Cancer?
New research reveals that an emerging deep learning tool had comparable sensitivity and specificity to radiologist assessment of contrast-enhanced computed tomography (CT) scans for pancreatic cancer, and a 74.7 percent sensitivity rate for tumors smaller than 2 cm.
CT AI Software for Fracture Risk Gets Breakthrough Device Designation from FDA
Assessing high-resolution computed tomography (CT) scans of the wrist, CurveBeam AI’s OssView software reportedly enables clinicians to ascertain bone fragility and fracture risk for women over the age of 70.
Managing Incidentalomas in Radiology: Embracing Challenges as Opportunities
September 12th 2022Greater imaging utilization has increased the prevalence of incidental findings or incidentalomas, but unclear clinical context and guidelines complicate management. Accordingly, these authors offer a thorough review of the literature and discuss new opportunities for improving interdisciplinary management strategies.